Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO May, 2011 | Pubmed ID: 21048039